Clinical trial
Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With…
NCT00171964 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00171964 |
|---|---|
| Title | Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions |
| Official title | Evaluation of the Efficacy and Tolerability of Zoledronic Acid in Combination With Radiotherapy in Patients With Advanced Osteolytic Bone Lesions |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain, Neoplasm Metastasis, Cancer |
| Intervention type | Drug |
| Interventions | Zoledronic acid in combination with therapy |
| Enrollment | 75 |
| Start date | May 1, 2002 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 1, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: